Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) shares passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.88 and traded as high as $1.84. Mesoblast shares last traded at $1.84, with a volume of 5,246 shares changing hands.
Mesoblast Price Performance
The firm’s fifty day simple moving average is $1.17 and its two-hundred day simple moving average is $0.89.
About Mesoblast
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Read More
- Five stocks we like better than Mesoblast
- How Technical Indicators Can Help You Find Oversold Stocks
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- 3 Fintech Stocks With Good 2021 Prospects
- Top 3 ETFs to Hedge Against Inflation in 2025
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
